Perrier A - Search Results

1

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.

Perrier A, Didelot A, Laurent-Puig P, Blons H, Garinet S. Perrier A, et al. Biomolecules. 2020 Jul 16;10(7):1061. doi: 10.3390/biom10071061. Biomolecules. 2020. PMID: 32708698 Free PMC article. Review.

2

Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.

Garinet S, Didelot A, Denize T, Perrier A, Beinse G, Leclere JB, Oudart JB, Gibault L, Badoual C, Le Pimpec-Barthes F, Laurent-Puig P, Legras A, Blons H. Garinet S, et al. Among authors: perrier a. Br J Cancer. 2021 Nov;125(11):1544-1551. doi: 10.1038/s41416-021-01568-7. Epub 2021 Oct 12. Br J Cancer. 2021. PMID: 34642464 Free PMC article.

3

Lynch syndrome: influence of additional susceptibility variants on cancer risk.

Vibert R, Hasnaoui J, Perrier A, Lefebvre A, Colas C, Dhooge M, Basset N, Chansavang A, Desseignes C, Duval A, Farelly S, Hamzaoui N, Laurent-Puig P, Metras J, Moliere D, Muleris M, Netter J, Touat M, Bielle F, Labreche K, Nicolle R, Perkins G, Warcoin M, Coulet F, Benusiglio PR. Vibert R, et al. Among authors: perrier a. Eur J Hum Genet. 2023 Sep;31(9):1078-1082. doi: 10.1038/s41431-023-01367-z. Epub 2023 Apr 24. Eur J Hum Genet. 2023. PMID: 37088804

4

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies.

Perrier A, Boelle PY, Chrétien Y, Gligorov J, Lotz JP, Brault D, Comperat E, Lefèvre G, Boissan M. Perrier A, et al. PLoS One. 2020 Jan 7;15(1):e0227356. doi: 10.1371/journal.pone.0227356. eCollection 2020. PLoS One. 2020. PMID: 31910438 Free PMC article.

5

[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].

Perrier A, Hainaut P, Guenoun A, Nguyen DP, Lamy PJ, Guerber F, Troalen F, Denis JA, Boissan M. Perrier A, et al. Bull Cancer. 2022 Feb;109(2):170-184. doi: 10.1016/j.bulcan.2021.12.005. Epub 2022 Jan 13. Bull Cancer. 2022. PMID: 35034786 Free article. Review. French.

6

Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability.

Ratovomanana T, Nicolle R, Cohen R, Diehl A, Siret A, Letourneur Q, Buhard O, Perrier A, Guillerm E, Coulet F, Cervera P, Benusiglio P, Labrèche K, Colle R, Collura A, Despras E, Le Rouzic P, Renaud F, Cros J, Alentorn A, Touat M, Ayadi M, Bourgoin P, Prunier C, Tournigand C, Fouchardière C, Tougeron D, Jonchère V, Bennouna J, de Reynies A, Fléjou JF, Svrcek M, André T, Duval A. Ratovomanana T, et al. Among authors: perrier a. Ann Oncol. 2023 Aug;34(8):703-713. doi: 10.1016/j.annonc.2023.05.010. Epub 2023 Jun 1. Ann Oncol. 2023. PMID: 37269904

7

The extracellular domain of Her2 in serum as a biomarker of breast cancer.

Perrier A, Gligorov J, Lefèvre G, Boissan M. Perrier A, et al. Lab Invest. 2018 Jun;98(6):696-707. doi: 10.1038/s41374-018-0033-8. Epub 2018 Feb 28. Lab Invest. 2018. PMID: 29491426 Free article. Review.

8

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports.

Michaux L, Perrier A, Mehlman C, Alshehhi H, Dubois A, Lacave R, Coulet F, Cadranel J, Fallet V. Michaux L, et al. Among authors: perrier a. Front Oncol. 2023 Jun 28;13:1182558. doi: 10.3389/fonc.2023.1182558. eCollection 2023. Front Oncol. 2023. PMID: 37448514 Free PMC article.

9

[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores].

Perrier A, Hainaut P, Lamy PJ, Guenoun A, Nguyen DP, Guerber F, Troalen F, Denis JA, Boissan M. Perrier A, et al. Bull Cancer. 2022 Feb;109(2):151-169. doi: 10.1016/j.bulcan.2021.11.010. Epub 2022 Jan 7. Bull Cancer. 2022. PMID: 35012767 Free article. Review. French.

10

[Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives].

Denis JA, Perrier A, Nectoux J, Lamy PJ, Alary AS, Sarafan-Vasseur N, Henaff D, Busser B, Appay R, Pedini P, Romanet P, Taly V, Fina F. Denis JA, et al. Among authors: perrier a. Ann Biol Clin (Paris). 2019 Dec 1;77(6):619-637. doi: 10.1684/abc.2019.1502. Ann Biol Clin (Paris). 2019. PMID: 31859639 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

490 results

Search Page